RVMD logo

Revolution Medicines (RVMD) Cash from operations

annual CFO:

-$557.44M-$206.86M(-59.01%)
December 31, 2024

Summary

  • As of today (June 22, 2025), RVMD annual cash flow from operations is -$557.44 million, with the most recent change of -$206.86 million (-59.01%) on December 31, 2024.
  • During the last 3 years, RVMD annual CFO has fallen by -$410.26 million (-278.74%).
  • RVMD annual CFO is now -46055.15% below its all-time high of $1.21 million, reached on December 31, 2018.

Performance

RVMD Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRVMDcash flow metrics

quarterly CFO:

-$194.44M-$56.15M(-40.60%)
March 31, 2025

Summary

  • As of today (June 22, 2025), RVMD quarterly cash flow from operations is -$194.44 million, with the most recent change of -$56.15 million (-40.60%) on March 31, 2025.
  • Over the past year, RVMD quarterly CFO has dropped by -$33.88 million (-21.10%).
  • RVMD quarterly CFO is now -1590.45% below its all-time high of -$11.50 million, reached on June 30, 2019.

Performance

RVMD quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRVMDcash flow metrics

TTM CFO:

-$591.31M-$33.88M(-6.08%)
March 31, 2025

Summary

  • As of today (June 22, 2025), RVMD TTM cash flow from operations is -$591.31 million, with the most recent change of -$33.88 million (-6.08%) on March 31, 2025.
  • Over the past year, RVMD TTM CFO has dropped by -$142.57 million (-31.77%).
  • RVMD TTM CFO is now -4591.08% below its all-time high of -$12.61 million, reached on March 31, 2019.

Performance

RVMD TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRVMDcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

RVMD Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-59.0%-21.1%-31.8%
3 y3 years-278.7%-252.5%-258.2%
5 y5 years-1023.5%-594.0%-809.3%

RVMD Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-278.7%at low-275.8%at low-258.2%at low
5 y5-year-1023.5%at low-872.6%at low-809.3%at low
alltimeall time<-9999.0%at low-1590.5%at low-4591.1%at low

RVMD Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
-$194.44M(+40.6%)
-$591.31M(+6.1%)
Dec 2024
-$557.44M(+59.0%)
-$138.29M(+6.0%)
-$557.44M(+3.3%)
Sep 2024
-
-$130.42M(+1.8%)
-$539.71M(+5.9%)
Jun 2024
-
-$128.17M(-20.2%)
-$509.79M(+13.6%)
Mar 2024
-
-$160.56M(+33.2%)
-$448.74M(+28.0%)
Dec 2023
-$350.57M(+56.2%)
-$120.56M(+20.0%)
-$350.57M(+20.1%)
Sep 2023
-
-$100.50M(+49.7%)
-$291.80M(+20.1%)
Jun 2023
-
-$67.12M(+7.6%)
-$243.04M(+4.9%)
Mar 2023
-
-$62.39M(+1.0%)
-$231.63M(+3.2%)
Dec 2022
-$224.40M(+52.5%)
-$61.79M(+19.4%)
-$224.40M(+11.2%)
Sep 2022
-
-$51.74M(-7.1%)
-$201.88M(+8.1%)
Jun 2022
-
-$55.72M(+1.0%)
-$186.73M(+13.1%)
Mar 2022
-
-$55.16M(+40.5%)
-$165.09M(+12.2%)
DateAnnualQuarterlyTTM
Dec 2021
-$147.18M(+47.1%)
-$39.27M(+7.3%)
-$147.18M(+10.7%)
Sep 2021
-
-$36.59M(+7.4%)
-$132.95M(+7.8%)
Jun 2021
-
-$34.08M(-8.5%)
-$123.38M(+12.9%)
Mar 2021
-
-$37.25M(+48.8%)
-$109.29M(+9.2%)
Dec 2020
-$100.06M(+101.7%)
-$25.03M(-7.4%)
-$100.06M(+15.4%)
Sep 2020
-
-$27.02M(+35.2%)
-$86.68M(+17.9%)
Jun 2020
-
-$19.99M(-28.6%)
-$73.52M(+13.1%)
Mar 2020
-
-$28.02M(+140.5%)
-$65.03M(+31.1%)
Dec 2019
-$49.62M(-4190.4%)
-$11.65M(-15.9%)
-$49.62M(+30.7%)
Sep 2019
-
-$13.86M(+20.5%)
-$37.96M(+57.5%)
Jun 2019
-
-$11.50M(-8.8%)
-$24.11M(+91.2%)
Mar 2019
-
-$12.61M
-$12.61M
Dec 2018
$1.21M(-104.8%)
-
-
Dec 2017
-$25.15M
-
-

FAQ

  • What is Revolution Medicines annual cash flow from operations?
  • What is the all time high annual CFO for Revolution Medicines?
  • What is Revolution Medicines annual CFO year-on-year change?
  • What is Revolution Medicines quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Revolution Medicines?
  • What is Revolution Medicines quarterly CFO year-on-year change?
  • What is Revolution Medicines TTM cash flow from operations?
  • What is the all time high TTM CFO for Revolution Medicines?
  • What is Revolution Medicines TTM CFO year-on-year change?

What is Revolution Medicines annual cash flow from operations?

The current annual CFO of RVMD is -$557.44M

What is the all time high annual CFO for Revolution Medicines?

Revolution Medicines all-time high annual cash flow from operations is $1.21M

What is Revolution Medicines annual CFO year-on-year change?

Over the past year, RVMD annual cash flow from operations has changed by -$206.86M (-59.01%)

What is Revolution Medicines quarterly cash flow from operations?

The current quarterly CFO of RVMD is -$194.44M

What is the all time high quarterly CFO for Revolution Medicines?

Revolution Medicines all-time high quarterly cash flow from operations is -$11.50M

What is Revolution Medicines quarterly CFO year-on-year change?

Over the past year, RVMD quarterly cash flow from operations has changed by -$33.88M (-21.10%)

What is Revolution Medicines TTM cash flow from operations?

The current TTM CFO of RVMD is -$591.31M

What is the all time high TTM CFO for Revolution Medicines?

Revolution Medicines all-time high TTM cash flow from operations is -$12.61M

What is Revolution Medicines TTM CFO year-on-year change?

Over the past year, RVMD TTM cash flow from operations has changed by -$142.57M (-31.77%)
On this page